Careers
Careers
Shape the future of our company
Welcome to the Quotient careers page.
We currently have a wide array of career opportunities available spanning a variety of professional disciplines, including research and development, manufacturing, quality management, commercial planning, and corporate support functions.


Joining Quotient represents a fantastic opportunity to become part of a team that will shape the future of the company and contribute to efforts to fundamentally transform transfusion diagnostics. If you want to take the next step in your career in a thriving, positive, and collegiate environment, Quotient could be the place for you.

Explore our Organization

Explore our Organization

Have you ever wondered what it is like to work as a member of a cutting-edge team?

Working at Quotient may well be unlike any other job in the world. There’s so much on offer. Innovation. Scientific breakthroughs. New product development and production growth. Lifesaving technology. Not to mention amazing personal and career development opportunities and the staff association nights. Interested?
Learn more

Life at Quotient

We are committed to delivering solutions that drive continual improvement; as such, we incessantly rethink the way in-vitro diagnostics is practiced. Discover what life is like as a member of the Quotient team.
Learn more
Life at Quotient

Love what we do

1
2
3
4

Our Hiring Process

Learn how to apply, review resume and interview tips and get answers to frequently asked questions.
Learn more

Latest updates

Virus
News
Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody test

JERSEY, Channel Islands, 28 September 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S.

Quotient laboratory
News
Quotient Limited to Publish Quarterly Investor Presentation

JERSEY, Channel Islands, August 4, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020.

Quotient laboratory
News
Quotient Limited Reports First Quarter Fiscal 2021 Results and Business Update

•    Significant progress in three targeted areas of MosaiQ development – COVID-19 antibody test, potential new applications, and transfusion diagnostics 
•    Ten commercial placements of MosaiQ platform in Europe and the US

Quotient laboratory
News
Quotient Announces Equity Awards

JERSEY, Channel Islands, 23 July 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced that Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D.

Quotient laboratory
News
Quotient Announces Appointment of Two New Board Members

JERSEY, Channel Islands, 23 July 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced changes in the composition of its board of directors that will take effect later this year.

Lab
News
Quotient Limited Reports Impressive Results from an Independent SARS-CoV-2 Antibody Detection Study Conducted in Spain

JERSEY, Channel Islands, July 20, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported that an independent study conducted in Madrid, Spain has confirmed the high perform

View all